Lexicon Pharmaceuticals Inc

Most Recent

  • uploads///joshua coleman  unsplash
    Company & Industry Overviews

    Why Achaogen Stock Fell Steeply Yesterday

    Yesterday, Achaogen (AKAO) announced that the FDA had approved its antibacterial agent, Zemdri (plazomicin), for adults suffering from complicated urinary tract infections (or cUTI) who don’t have significant treatment options.

    By Margaret Patrick
  • uploads///Graph Part  Oct
    Company & Industry Overviews

    Grifols and Myriad Traded above the 100-Day Moving Averages

    Grifols (GRFS) only fell by 0.34%. It bucked the trend. There were talks that Moody’s upgraded the ratings from “negative” to “stable.”

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.